Chemical Structure : ALG1001
Catalog No.: PC-35165Not For Human Use, Lab Use Only.
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis; ALG1001 inhibits an integrin-mediated pathway of the vitreoretinal interface, connecting the posterior aspect of the vitreous with the internal limiting membrane of the retina. In blocking this pathway, ALG-1001 helps to achieve vitreous breakdown and separation from the retina.
Other Indication
Phase 2 Clinical
M.Wt | 637.666 | |
Formula | C22H39N9O11S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright